Camélia Benlabiod

机构：National Institute for Health and Care Research, MRC Weatherall Institute of Molecular Medicine, MRC Human Immunology Unit, Oxford BioMedica (United Kingdom) · ORCID：0000-0001-7119-9326

发表论文 23 篇 · 总被引 200 次 · h-index 8

代表论文

• Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN (2020 · Nature Communications · 被引 44)
• A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis (2024 · Science Translational Medicine · 被引 36)
• Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA (2025 · Science · 被引 33)
• SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice (2023 · Leukemia · 被引 18)
• Development of a First-in-Class CAR-T Therapy Against Calreticulin-Mutant Neoplasms and Evaluation in the Relevant Human Tissue Environment (2024 · Blood · 被引 14)
• HSPCs display within-family homogeneity in differentiation and proliferation despite population heterogeneity (2021 · eLife · 被引 12)